LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | 4.55%1.22B | 4.55%1.22B | -12.07%1.36B | 3.26%1.36B | -40.06%1.21B | 4.40%1.17B | 4.40%1.17B | 16.12%1.55B | -42.82%1.32B | -46.80%2.02B |
-Cash and cash equivalents | 4.55%1.22B | 4.55%1.22B | 463.64%1.36B | 378.72%1.36B | 354.67%1.21B | 4.40%1.17B | 4.40%1.17B | -10.42%241.14M | -17.67%284.55M | 3.53%266.4M |
-Money market investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 22.85%1.3B | -47.25%1.03B | -50.46%1.75B |
Net loan | 3.39%20.93B | 3.39%20.93B | 4.39%21.18B | 3.09%21.23B | 2.45%20.64B | 1.01%20.24B | 1.01%20.24B | 7.25%20.29B | 14.75%20.59B | 19.34%20.15B |
-Gross loan | 3.49%21.27B | 3.49%21.27B | 4.55%21.52B | 3.35%21.56B | 2.80%20.96B | 1.50%20.55B | 1.50%20.55B | 7.73%20.58B | 15.16%20.86B | 19.64%20.39B |
-Allowance for loans and lease losses | 10.09%338.08M | 10.09%338.08M | 15.29%334.46M | 23.58%336.22M | 31.88%320.02M | 49.31%307.1M | 49.31%307.1M | 56.91%290.1M | 57.59%272.07M | 50.48%242.66M |
Securities and investments | 17.69%1.9B | 17.69%1.9B | -0.25%1.67B | 3.72%1.78B | -7.81%1.64B | -7.43%1.62B | -7.43%1.62B | 15.56%1.67B | 41.13%1.71B | 146.89%1.78B |
-Available for sale securities | -7.66%66.3M | -7.66%66.3M | -39.12%63.9M | -11.89%96.61M | -47.19%77.48M | -35.32%71.79M | -35.32%71.79M | 73.31%104.96M | 121.53%109.66M | 197.02%146.72M |
-Held to maturity securities | 16.37%164.68M | 16.37%164.68M | 13.65%161.22M | 4.23%148.54M | 9.57%147.02M | 4.93%141.51M | 4.93%141.51M | 8.94%141.86M | 27.64%142.51M | 46.71%134.18M |
-Short term investments | 19.13%1.67B | 19.13%1.67B | 1.23%1.44B | 4.84%1.53B | -5.51%1.41B | -6.47%1.4B | -6.47%1.4B | 13.46%1.42B | 38.78%1.46B | 158.43%1.5B |
Bank owned life insurance | 3.23%408.57M | 3.23%408.57M | 17.00%460.7M | -3.84%376.46M | 1.95%396.8M | 1.90%395.78M | 1.90%395.78M | 1.87%393.77M | 1.72%391.48M | 16.91%389.2M |
Net PPE | -3.22%209.46M | -3.22%209.46M | -3.05%210.93M | -2.47%213.26M | -1.86%214.8M | -1.75%216.44M | -1.75%216.44M | -2.30%217.56M | -2.49%218.66M | -2.41%218.88M |
-Gross PPE | ---- | ---- | ---- | ---- | ---- | 1.41%337.79M | 1.41%337.79M | ---- | ---- | ---- |
-Accumulated depreciation | ---- | ---- | ---- | ---- | ---- | -7.57%-121.36M | -7.57%-121.36M | ---- | ---- | ---- |
Foreclosed assets | -60.75%2.43M | -60.75%2.43M | 179.13%9.48M | -64.13%2.21M | 43.68%2.16M | 635.35%6.2M | 635.35%6.2M | 302.97%3.4M | 638.92%6.17M | -21.36%1.5M |
Goodwill and other intangible assets | -1.56%1.09B | -1.56%1.09B | -1.57%1.09B | -1.59%1.09B | -1.61%1.1B | -1.63%1.1B | -1.63%1.1B | -2.29%1.11B | -2.30%1.11B | -2.27%1.12B |
-Goodwill | 0.00%1.02B | 0.00%1.02B | 0.00%1.02B | 0.00%1.02B | 0.00%1.02B | 0.00%1.02B | 0.00%1.02B | -0.73%1.02B | -0.72%1.02B | -0.66%1.02B |
-Other intangible assets | -19.54%70.76M | -19.54%70.76M | -18.87%74.94M | -18.26%79.12M | -17.70%83.53M | -17.18%87.95M | -17.18%87.95M | -16.71%92.38M | -16.27%96.8M | -15.96%101.49M |
Other assets | 10.46%502.14M | 10.46%502.14M | -10.22%418.35M | 4.46%469.08M | 8.48%447.77M | 9.22%454.6M | 9.22%454.6M | 25.07%465.97M | -5.38%449.04M | -9.37%412.78M |
Total assets | 4.20%26.26B | 4.20%26.26B | 2.73%26.4B | 2.79%26.52B | -1.66%25.66B | 0.60%25.2B | 0.60%25.2B | 7.91%25.7B | 8.92%25.8B | 10.73%26.09B |
Liabilities | ||||||||||
Total deposits | 4.90%21.72B | 4.90%21.72B | 6.26%21.88B | 4.90%21.44B | 5.53%21B | 6.40%20.71B | 6.40%20.71B | 5.77%20.59B | 3.85%20.44B | 1.58%19.9B |
Long term debt and capital lease obligation | -33.72%424.1M | -33.72%424.1M | -64.29%478.26M | -35.32%1.08B | -69.88%762.19M | -68.07%639.9M | -68.07%639.9M | 56.93%1.34B | 201.37%1.67B | 358.07%2.53B |
-Long term debt | -33.72%424.1M | -33.72%424.1M | -64.29%478.26M | -35.32%1.08B | -69.88%762.19M | -68.07%639.9M | -68.07%639.9M | 56.93%1.34B | 201.37%1.67B | 358.07%2.53B |
Other liabilities | -15.06%363.98M | -15.06%363.98M | -14.29%360.89M | 6.32%432.25M | 0.87%411.12M | 10.14%428.54M | 10.14%428.54M | 12.52%421.05M | 8.34%406.56M | -0.66%407.59M |
Total liabilities | 3.37%22.51B | 3.37%22.51B | 1.64%22.72B | 1.95%22.95B | -2.91%22.17B | -0.36%21.78B | -0.36%21.78B | 8.00%22.35B | 9.23%22.52B | 11.10%22.84B |
Shareholders'equity | ||||||||||
Share capital | 0.25%72.7M | 0.25%72.7M | 0.25%72.7M | 0.25%72.7M | 0.27%72.68M | 0.35%72.52M | 0.35%72.52M | 0.37%72.51M | 0.37%72.52M | 0.38%72.48M |
-common stock | 0.25%72.7M | 0.25%72.7M | 0.25%72.7M | 0.25%72.7M | 0.27%72.68M | 0.35%72.52M | 0.35%72.52M | 0.37%72.51M | 0.37%72.52M | 0.38%72.48M |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Paid-in capital | 0.68%1.96B | 0.68%1.96B | 0.60%1.95B | 0.57%1.95B | 0.55%1.95B | 0.53%1.95B | 0.53%1.95B | 0.51%1.94B | 0.45%1.94B | 0.46%1.94B |
Retained earnings | 20.36%1.85B | 20.36%1.85B | 19.44%1.77B | 19.05%1.68B | 17.71%1.6B | 17.44%1.54B | 17.44%1.54B | 19.76%1.48B | 22.24%1.41B | 26.42%1.36B |
Less: Treasury stock | 8.36%103.13M | 8.36%103.13M | 12.21%103.13M | 12.25%103.13M | 19.41%100.17M | 27.19%95.17M | 27.19%95.17M | 22.82%91.9M | 23.01%91.87M | 20.46%83.88M |
Gains losses not affecting retained earnings | 16.19%-30.12M | 16.19%-30.12M | 74.15%-15.72M | 24.89%-38.02M | -12.30%-39.96M | 22.72%-35.94M | 22.72%-35.94M | -19.88%-60.82M | -300.62%-50.62M | -1,832.70%-35.58M |
Total stockholders'equity | 9.48%3.75B | 9.48%3.75B | 9.99%3.68B | 8.58%3.57B | 7.12%3.48B | 7.17%3.43B | 7.17%3.43B | 7.31%3.35B | 6.87%3.28B | 8.18%3.25B |
Total equity | 9.48%3.75B | 9.48%3.75B | 9.99%3.68B | 8.58%3.57B | 7.12%3.48B | 7.17%3.43B | 7.17%3.43B | 7.31%3.35B | 6.87%3.28B | 8.18%3.25B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |